Llaguno-Munive, M.; Romero-Piña, M.; Serrano-Bello, J.; Medina, L.A.; Uribe-Uribe, N.; Salazar, A.M.; Rodríguez-Dorantes, M.; Garcia-Lopez, P.
Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma. Cancers 2019, 11, 16.
https://doi.org/10.3390/cancers11010016
AMA Style
Llaguno-Munive M, Romero-Piña M, Serrano-Bello J, Medina LA, Uribe-Uribe N, Salazar AM, Rodríguez-Dorantes M, Garcia-Lopez P.
Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma. Cancers. 2019; 11(1):16.
https://doi.org/10.3390/cancers11010016
Chicago/Turabian Style
Llaguno-Munive, Monserrat, Mario Romero-Piña, Janeth Serrano-Bello, Luis A. Medina, Norma Uribe-Uribe, Ana Maria Salazar, Mauricio Rodríguez-Dorantes, and Patricia Garcia-Lopez.
2019. "Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma" Cancers 11, no. 1: 16.
https://doi.org/10.3390/cancers11010016
APA Style
Llaguno-Munive, M., Romero-Piña, M., Serrano-Bello, J., Medina, L. A., Uribe-Uribe, N., Salazar, A. M., Rodríguez-Dorantes, M., & Garcia-Lopez, P.
(2019). Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma. Cancers, 11(1), 16.
https://doi.org/10.3390/cancers11010016